Table 1.
Summary of similarities and differences in published nanobodies
Nanobody | Method | Neutralizing pseudovirus (IC50) | Affinity to RBD | Function | References |
---|---|---|---|---|---|
VHH-E | Immunized phage display library | 60 nM | 1.86 nM | Blocking RBD-ACE2 interaction/prevent the emergence of viral escape mutants | [90] |
Nb11-59 | Immunized phage display library | 36.7 nM | 21 nM | Blocking RBD-ACE2 interaction/high binding activity to the RBD | [34] |
Sybody (n3021) | Ribosome and phage display | – | 0.63 nM | Blocking RBD-ACE2 interaction/binding to the full-length SARS-CoV-2 spike protein | [91] |
Sybody (MR3) | Ribosome and phage display | 40 nM | 24.22 nM | Blocking RBD-ACE2 interaction | [92] |
Nb6 | yeast surface-displayed library | 2 uM | 210 nM | Blocking RBD-ACE2 interaction/Binding Spike in a fully inactive conformation with its receptor binding domains | [93] |
H11-D4 | naive llama single-domain antibody library | – | 39 nM | Blocking RBD-ACE2 interaction/Binding to all three RBDs in the spike trimer | [94] |
H11-H4 | naive llama single-domain antibody library | – | 12 nM | Blocking RBD-ACE2 interaction/Binding to all three RBDs in the spike trimer | [94] |
Ty1 | Immunized phage display library | 54 nM | 5–10 nM | Blocking RBD-ACE2 interaction/Binding to the RBD with high affinity | [95] |
Nbs 89 | Immune library and MS proteomic | 0.133 nM | 108 pM | Blocking RBD-ACE2 interaction/inhibit viral infection | [96] |
WNb | Immunized phage display library | – | ≤ 80 nM | Blocking RBD-ACE2 interaction/neutralize both wildtype SARS-CoV-2 and the N501Y D614G variant | [4] |